This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. rose 5.7% to $491.47 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 6,836.17 and the Dow Jones Industrial Average rising 0.1% to 49,500.93.
This was the stock's second consecutive day of gains.
Vertex Pharmaceuticals Inc. closed 5.4% below its 52-week high of $519.68, which the company achieved on March 14th.
The stock outperformed some of its peers, as AbbVie Inc. rose 1.8% to $231.50, Krystal Biotech Inc. rose 2.3% to $276.45, and Arcturus Therapeutics Holdings Inc. rose 0.56% to $7.21.
Trading volume totaled 2.9 million, compared to the 50-day average of 1.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 13, 2026 16:34 ET (21:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.